Safety, efficacy and impact on patients' quality of life of a long-term treatment with the α1-blocker alfuzosin in symptomatic patients with BPH

European Urology

Volumn 37, Issue 6, 2000, Pages 680-686

  Barbui, P ^a   Casadei, G ^a   Ceccopieri, C ^a   Ciotola, R ^a   Comeri, G ^a   Cruciani, E ^a   De Joanna, F ^a   Ferrando, U ^a   Gritti, A ^a   Guarna, A ^a   Jacobellis, U ^a   Lai, S ^a   Leoni, S ^a   Maccanico, A ^a   Miano, L ^a   Milani, C ^a   Borin, R ^a   Nicolosi, D ^a   Pacifico, P ^a   Parma, A ^a   Rocca Rossetti, S ^a   Sacca, V ^a   Trocino, S ^a   Valentino, R V ^a   Varaldo, M ^a   more..

^a SANT ANNA HOSPITAL   (Italy)

Author keywords

Alfuzosin; BPH; Quality of life

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CHOLINERGIC RECEPTOR BLOCKING AGENT; MONOAMINE OXIDASE INHIBITOR;

ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; LONG TERM CARE; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RESIDUAL URINE; SCORING SYSTEM; TACHYCARDIA; URINE FLOW RATE; VERTIGO; VOMITING;

EID: 0034057459     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020218     Document Type: Article

References (27)